Eagle Pharmaceutical (NASDAQ: EGRX)
| Last Price | $80.04 |
| Net Change | $-2.81 (-3.39%) |
| Bid | $0 |
| Ask Price | $0 |
| Open Price | $82.57 |
| Previous Close Price | $82.85 |
| High Price | $83.6 |
| Low Price | $79.78 |
| Number of Trades | 1,422 |
| Volume | 249,028 |
| Fifty Two Week High | $97.15 (2017-05-10) |
| Fifty Two Week Low | $35.32 (2016-06-28) |
| Average Daily Volume | 336,429 |
| Share Outstanding | 15,300 Shares |
| Total Dividend Payout | 0/yr |
| Dividend Yield | 0% |
| 1st Quarter Earnings | $1.42 (2017-05-08) |
| 2nd Quarter Earnings | $3.52 (2017-03-01) |
| 3nd Quarter Earnings | $0.73 (2016-11-09) |
| 4th Quarter Earnings | $0.8 (2016-08-09) |
| PE Ratio | $12.81 |
| EPS Growth | $-27.62 |
| Recent Earnings | $1.42 |
| Annual EPS | $6.47 |
| Last Quarter EPS | $ |
| Market Capitalization | $1.22B |
| Insider Shareholders % | 0.188% |
| Annual Revenue | $0B |
| No. Shares Outstanding | 15,300 |
| Inst. Shareholder % | 0% |
| Annual Net Income | $0.11B |
| TTM Net Profit Margin | $44.48 |
| 1-Year Return | 113.9% |
| 3-Year Return | 458.55% |
| 5-Year Return | 523.85% |
| 5-Year Revenue Growth | 0% |
| 5-Year Earnings Growth | 0% |
| 5-Year Dividend Growth | 0% |
| Annual Dividend | $0 |
| Annual Dividend Yield | 0% |
| Change in EPS YTD | -27.620001% |
| Dividends per Share | $ |
| Stock Split Ratio | |
| Beta | 1.48 |
No News found for EGRX